Jyong Biotech targets urinary disorders with a novel botanical pipeline, but clinical and liquidity risks temper near-term ...

The global statistics are terrifying. Prostate cancer is the fourth most common cancer in all populations, the second most ...

Men on active surveillance for low- to intermediate-risk prostate cancer (PCa) have low risk for PCa-related mortality at a median follow-up of 18 years. However, a majority of men do progress and ...

With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent ...

Results of a study led by VHIO’s Prostate Cancer Group suggest that treatment with CDK4/6 inhibitors followed by senloytic ...

Cardiac biomarkers may not only be indicative of cardiac events, but could also be predictive of future cancer diagnosis, ...

A Flinders University study shows that bowel cancer survivors face an elevated risk of developing multiple primary cancers ...

Although an elevated PSA measurement can indicate prostate cancer, there can be other reasons for elevated levels.

Even a little movement goes a long way. As Dr. George explains, just 75 minutes of activity a week, that’s about 11 minutes a ...

The TCR report forecasts that by 2032 prostate cancer will increase steadily and remain the number one cancer of concern ...

Prostate cancer focal therapies include cryotherapy, irreversible electroporation ablation (IRE), & high-intensity focused ultrasound (HIFU).